Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$8,815,552
+$402,417 QoQ
Shares Held
34,711
+0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.50%
of 13F equity value
Holder Rank
#1,188
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Relyea Zuckerberg Hanson LLC holds $22,750,410 across 8 Drug Manufacturers - General names. JNJ ranks #1 (38.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
34,711 | $8,815,552 | |
| 2 | ABBV |
AbbVie Inc.
|
27,498 | $6,919,596 | |
| 3 | LLY |
ELI LILLY & Co
|
3,409 | $4,088,857 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,095 | $1,297,207 | |
| 5 | AMGN |
Amgen Inc
|
1,624 | $588,082 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,176 | $401,255 | |
| 7 | PFE |
Pfizer Inc
|
13,950 | $335,916 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,275 | $303,945 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,815,552 | 34,711 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $8,413,135 | 34,418 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,524,719 | 31,528 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $5,841,471 | 31,504 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $4,314,423 | 28,245 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $5,399,087 | 32,556 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $4,928,071 | 34,076 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $2,871,379 | 17,718 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,558,092 | 17,502 | Shares | Sole | 2024-10-31 | |
| 2024-03-31 | $2,689,071 | 16,999 | Shares | Sole | 2024-10-31 | |
| 2023-12-31 | $2,530,880 | 16,147 | Shares | Sole | 2024-10-31 | |
| 2023-09-30 | $2,343,726 | 15,048 | Shares | Sole | 2024-10-31 | |
| 2023-06-30 | $2,639,712 | 15,948 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $2,343,445 | 15,119 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $2,475,749 | 14,015 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $1,801,534 | 11,028 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,932,373 | 10,886 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $1,780,098 | 10,044 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,464,359 | 8,560 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $1,344,487 | 8,325 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $1,321,873 | 8,024 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $1,241,335 | 7,553 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,180,979 | 7,504 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $1,129,552 | 7,587 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $1,091,851 | 7,764 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $1,021,502 | 7,790 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||